Physician profile
Corinne Cooper
NPI 1871515809
$1,653.44
in general payments reported to CMS, 2019-2025
16 companies · $981 in 2025
The $981 reported for 2025 was more than what 91% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $60.94 · 2021: $22.42 · 2022: $172 · 2023: $416 · 2025: $981.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,398.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,397.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaukos Corporation | $287.19 | 2025 | Idosetr |
| Alcon Vision LLC | $214.04 | 2023-2025 | Hydrus Microstent, Voyager Dslt, Precision7 |
| Abbvie INC. | $181.03 | 2023 | Xen Glaucoma Treatment System, Durysta, Alphagan P |
| Bausch & Lomb Americas INC. | $145.85 | 2023-2025 | Vyzulta, Toric |
| Tarsus Pharmaceuticals, INC. | $125.00 | 2025 | Xdemvy |
| Johnson & Johnson Vision Care, INC. | $116.20 | 2022-2023 | Acuvue |
| Coopervision INC. | $105.70 | 2022-2023 | Myday Contact Lens |
| Mallinckrodt Hospital Products INC. | $98.79 | 2023-2025 | Acthar |
| Sight Sciences, INC. | $98.30 | 2025 | Tearcare System, Omni Surgical System |
| Horizon Therapeutics Plc | $84.07 | 2023 | Tepezza |
| Sun Pharmaceutical Industries INC. | $51.20 | 2021-2025 | |
| Maculogix, INC. | $44.95 | 2019 | |
| Dompe US, INC. | $32.82 | 2025 | Oxervate |
| Genentech USA, INC. | $28.98 | 2025 | Vabysmo |
| Amgen INC. | $23.33 | 2025 | Tepezza |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abb Con-Cise Optical Group LLC | $15.99 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Corinne Cooper listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.